142 related articles for article (PubMed ID: 10508482)
1. Hepatocyte growth factor (HGF) in ovarian epithelial tumour fluids stimulates the migration of ovarian carcinoma cells.
Sowter HM; Corps AN; Smith SK
Int J Cancer; 1999 Nov; 83(4):476-80. PubMed ID: 10508482
[TBL] [Abstract][Full Text] [Related]
2. Comparison of hepatocyte growth factor levels of epithelial ovarian cancer cyst fluids with benign ovarian cysts.
Baykal C; Demirtaş E; Al A; Ayhan A; Yüce K; Tulunay G; Köse MF; Ayhan A
Int J Gynecol Cancer; 2004; 14(1):152-6. PubMed ID: 14764044
[TBL] [Abstract][Full Text] [Related]
3. Comparison of HGF (hepatocyte growth factor) levels of epithelial ovarian cancer cyst fluids with benign ovarian cysts.
Baykal C; Demirtas E; Al A; Ayhan A; Yuce K; Tulunay G; Kose MF; Ayhan A
Int J Gynecol Cancer; 2003; 13(6):771-5. PubMed ID: 14675313
[TBL] [Abstract][Full Text] [Related]
4. Hepatocyte growth factor stimulates motility, chemotaxis and mitogenesis in ovarian carcinoma cells expressing high levels of c-met.
Corps AN; Sowter HM; Smith SK
Int J Cancer; 1997 Sep; 73(1):151-5. PubMed ID: 9334823
[TBL] [Abstract][Full Text] [Related]
5. Higher levels of soluble E-cadherin in cyst fluid from malignant ovarian tumours than in benign cysts.
Sundfeldt K; Ivarsson K; Rask K; Haeger M; Hedin L; Brännström M
Anticancer Res; 2001; 21(1A):65-70. PubMed ID: 11299791
[TBL] [Abstract][Full Text] [Related]
6. Ovarian cancer ascites enhance the migration of patient-derived peritoneal mesothelial cells via cMet pathway through HGF-dependent and -independent mechanisms.
Matte I; Lane D; Laplante C; Garde-Granger P; Rancourt C; Piché A
Int J Cancer; 2015 Jul; 137(2):289-98. PubMed ID: 25482018
[TBL] [Abstract][Full Text] [Related]
7. Ovarian cancer-derived ascitic fluids induce a senescence-dependent pro-cancerogenic phenotype in normal peritoneal mesothelial cells.
Mikuła-Pietrasik J; Uruski P; Matuszkiewicz K; Szubert S; Moszyński R; Szpurek D; Sajdak S; Tykarski A; Książek K
Cell Oncol (Dordr); 2016 Oct; 39(5):473-481. PubMed ID: 27444787
[TBL] [Abstract][Full Text] [Related]
8. Expression and action of hepatocyte growth factor in human and bovine normal ovarian surface epithelium and ovarian cancer.
Parrott JA; Skinner MK
Biol Reprod; 2000 Mar; 62(3):491-500. PubMed ID: 10684788
[TBL] [Abstract][Full Text] [Related]
9. Hepatocyte growth factor/scatter factor stimulates chemotaxis and growth of malignant mesothelioma cells through c-met receptor.
Klominek J; Baskin B; Liu Z; Hauzenberger D
Int J Cancer; 1998 Apr; 76(2):240-9. PubMed ID: 9537587
[TBL] [Abstract][Full Text] [Related]
10. Vascular endothelial growth factor levels in ovarian cyst fluid correlate with malignancy.
Hazelton D; Nicosia RF; Nicosia SV
Clin Cancer Res; 1999 Apr; 5(4):823-9. PubMed ID: 10213218
[TBL] [Abstract][Full Text] [Related]
11. Differential processing of type I and type III procollagens in the tumour cysts and peritoneal ascitic fluid of patients with benign and malignant ovarian tumours.
Zhu GG; Melkko J; Risteli J; Kauppila A; Risteli L
Clin Chim Acta; 1994 Sep; 229(1-2):87-97. PubMed ID: 7988058
[TBL] [Abstract][Full Text] [Related]
12. Early inflammatory response in epithelial ovarian tumor cyst fluids.
Kristjánsdóttir B; Partheen K; Fung ET; Yip C; Levan K; Sundfeldt K
Cancer Med; 2014 Oct; 3(5):1302-12. PubMed ID: 24947406
[TBL] [Abstract][Full Text] [Related]
13. A comparison of the growth promoting properties of ascitic fluids, cyst fluids and peritoneal fluids from patients with ovarian tumours.
Wilson AP; Fox H; Scott IV; Lee H; Dent M; Golding PR
Br J Cancer; 1991 Jan; 63(1):102-8. PubMed ID: 1989647
[TBL] [Abstract][Full Text] [Related]
14. Production of interleukin-1 beta and tumour necrosis factor-alpha in patients with benign or malignant ovarian tumours.
Punnonen J; Heinonen PK; Kuoppala T; Jansen CT; Punnonen R
J Cancer Res Clin Oncol; 1991; 117(6):587-92. PubMed ID: 1744165
[TBL] [Abstract][Full Text] [Related]
15. Apolipoprotein concentrations are elevated in malignant ovarian cyst fluids suggesting that lipoprotein metabolism is dysregulated in epithelial ovarian cancer.
Podzielinski I; Saunders BA; Kimbler KD; Branscum AJ; Fung ET; DePriest PD; van Nagell JR; Ueland FR; Baron AT
Cancer Invest; 2013 May; 31(4):258-72. PubMed ID: 23627408
[TBL] [Abstract][Full Text] [Related]
16. [Expressions of MACC1, HGF, and C-met protein in epithelial ovarian cancer and their significance].
Zhang RT; Shi HR; Huang HL; Chen ZM; Liu HN; Yuan ZF
Nan Fang Yi Ke Da Xue Xue Bao; 2011 Sep; 31(9):1551-5. PubMed ID: 21945764
[TBL] [Abstract][Full Text] [Related]
17. Progressive changes in Met-dependent signaling in a human ovarian surface epithelial model of malignant transformation.
Wong AS; Roskelley CD; Pelech S; Miller D; Leung PC; Auersperg N
Exp Cell Res; 2004 Sep; 299(1):248-56. PubMed ID: 15302591
[TBL] [Abstract][Full Text] [Related]
18. Hepatocyte growth factor secreted by ovarian cancer cells stimulates peritoneal implantation via the mesothelial-mesenchymal transition of the peritoneum.
Nakamura M; Ono YJ; Kanemura M; Tanaka T; Hayashi M; Terai Y; Ohmichi M
Gynecol Oncol; 2015 Nov; 139(2):345-54. PubMed ID: 26335595
[TBL] [Abstract][Full Text] [Related]
19. Vascular endothelial growth factor in adnexal masses.
Demirkiran F; Kumbak B; Bese T; Arvas M; Benian A; Aydin S; Uzun H; Sanioglu C; Aydinli K; Kösebay D
Int J Gynaecol Obstet; 2003 Oct; 83(1):53-8. PubMed ID: 14511872
[TBL] [Abstract][Full Text] [Related]
20. Gonadotropin (LH, FSH) levels in serum and cyst fluid in epithelial tumors of the ovary.
Chudecka-Głaz A; Rzepka-Górska I; Kosmowska B
Arch Gynecol Obstet; 2004 Nov; 270(3):151-6. PubMed ID: 12883823
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]